Maude St-Onge

Dr. Maude St-Onge completed her medical studies at the Université de Montréal in 2006, specialized in Emergency Medicine at Laval University in 2011, Critical Care at the University of Toronto in 2013, and Clinical Pharmacology and Toxicology at the University of Toronto in 2016. Dr. St-Onge obtained a Master’s Degree in Public Health in 2004 and a Ph.D. in Medical Sciences in 2015 from the University of Toronto. Her Ph.D. aimed at developing international recommendations for the management of calcium channel blocker poisoning and included a systematic review, a retrospective study, an economic study, a survey, and a Delphi.

Since July 2015 Dr. Maude St-Onge has been the medical director of the Centre antipoison du Québec, works as an intensivist clinician-scientist at the CHU de Québec, and as an associate professor for the Department of Family Medicine and Emergency Medicine, as well as the Laval University Department of Anesthesiology and Critical Care Medicine. Dr. St-Onge’s research interests concern acute care toxicology.

She is currently studying the factors influencing adherence to the recommendations she developed during her Ph.D. (qualitative study, matched crossover study), evaluating the risks and benefits related to the administration of activated charcoal to poisoned patients (Activated CHARcoal in Poisoned Patients-CHARPP: systematic review, retrospective study, survey, validation of a clinical score, pilot study, clinical trial), and working to better understand the continuum of care provided to Indigenous poisoned patients (CARe for Indigenous Poisoned Patients-CARIPP: scoping review, retrospective study, qualitative study). Indeed, activated charcoal is the most often recommended intervention by poison centers, and the Indigenous population is the most affected by poisonings.